Related references
Note: Only part of the references are listed.Chronic hypoparathyroidism and treatment with teriparatide
Gemma Marcucci et al.
ENDOCRINE (2021)
Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: a Belgium and the Netherlands survey
N. A. T. Hamdy et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
Changes in Skeletal Microstructure Through Four Continuous Years of rhPTH(1-84) Therapy in Hypoparathyroidism
Natalie E. Cusano et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety
Yu-Kwang Donovan Tay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism
Michael Mannstadt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus
Aliya A. Khan et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Body mass index predicts resistance to active vitamin D in patients with hypoparathyroidism
Anna Maria Formenti et al.
ENDOCRINE (2019)
Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism
Tamara J. Vokes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life
Andrea Palermo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy
Gemma Marcucci et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism
A. Meola et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study
Bart L. Clarke et al.
ENDOCRINE (2017)
AN OPEN-LABEL EXTENSION STUDY OF PARATHYROID HORMONE RHPTH(1-84) IN ADULTS WITH HYPOPARATHYROIDISM
Peter Lakatos et al.
ENDOCRINE PRACTICE (2016)
Natpara for the treatment of hypoparathyroidism
Gemma Marcucci et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Management of Hypoparathyroidism: Summary Statement and Guidelines
Maria Luisa Brandi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Epidemiology and Diagnosis of Hypoparathyroidism
Bart L. Clarke et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway
Marianne C. Astor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety
Mishaela R. Rubin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults
Jens Bollerslev et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study
Line Underbjerg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life
Assunta Santonati et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial
T. Sikjaer et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Cardiovascular and Renal Complications to Postsurgical Hypoparathyroidism: A Danish Nationwide Controlled Historic Follow-Up Study
Line Underbjerg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
The Effect of PTH(1-84) on Quality of Life in Hypoparathyroidism
Natalie E. Cusano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study
Michael Mannstadt et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Long-Term Follow-Up of Patients with Hypoparathyroidism
Deborah M. Mitchell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The Effect of Adding PTH(1-84) to Conventional Treatment of Hypoparathyroidism: A Randomized, Placebo-Controlled Study
Tanja Sikjaer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Hypoparathyroidism in the Adult: Epidemiology, Diagnosis, Pathophysiology, Target-Organ Involvement, Treatment, and Challenges for Future Research
John P. Bilezikian et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Long-Term Treatment of 12 Children with Chronic Hypoparathyroidism: A Randomized Trial Comparing Synthetic Human Parathyroid Hormone 1-34 versus Calcitriol and Calcium
Karen K. Winer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism
Karen K. Winer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Derivation and internal validation of an equation for albumin-adjusted calcium
Matthew James et al.
BMC CLINICAL PATHOLOGY (2008)
Long-term treatment of hypoparathyroidism:: A randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium
KK Winer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Share Paper
